[ad_1]
HKSTP joins “Suppose Enterprise, Suppose Hong Kong” symposium in Paris to spice up Hong Kong-French innovation and biotech ambitions
- HKSTP leads showcase of Hong Kong’s world-class biotech ecosystem as best platform to propel startups and large pharma to world scale and success.
- Asia Pacific is world’s quickest rising biotech area with a 16.9% compound annual progress fee from 2022 to 2030.
- “Suppose Enterprise, Suppose Hong Kong” symposium to function France’s Minister of Overseas Commerce and Hong Kong’s Monetary Secretary on 19 September on the Carrousel du Louvre in Paris.
HONG KONG SAR – Media OutReach – 14 September 2023 – Hong Kong Science and Expertise Parks Company (HKSTP), will be part of the “Suppose Enterprise, Suppose Hong Kong” symposium organised by Hong Kong Commerce Growth Council (HKTDC) on 19 September, on the Carrousel du Louvre in Paris.
Hong Kong’s largest innovation and know-how (I&T) ecosystem and incubator, HKSTP, will lead a contingent of well being and biotech leaders to stipulate how Hong Kong may help biotech start-ups and large pharma in France scale for fulfillment and faucet into the massive potential of Asia’s healthcare markets. On the similar time, French experience and expertise may even advance Hong Kong’s objective to grow to be a global biotech and innovation know-how hub.
Mr Olivier Becht, France’s Minister for Overseas Commerce, Financial Attractiveness and French Nationals Overseas and Mr Paul Chan, Monetary Secretary of the HKSAR Authorities, will be part of a solid of enterprise leaders on the occasion together with Dr Peter Lam, Chairman of HKTDC, and Mr Albert Wong, CEO of HKSTP to debate the collaboration potential between the French and the Hong Kong I&T ecosystems.
Asia Pacific is ready to be the world’s quickest rising biotech area with a 16.9% compound annual progress fee from 2022 to 2030, based on Imaginative and prescient Analysis. The area can also be seeing enhancing healthcare infrastructure, supportive authorities insurance policies and an more and more essential getting old inhabitants problem. Hong Kong is effectively situated as the best hub to each the massive markets in North Asia and various fast-growing SE Asian economies.
Quick-rising biotech stars
To debate these points and alternatives, HKSTP is internet hosting a biotech thematic session and pavilion on the “Suppose Enterprise, Suppose Hong Kong” symposium, with 4 main executives from fast-rising Hong Kong-based biotech ventures showcasing town’s potential to propel innovation to world success.
The 4 audio system and biotech firms embrace:
– Dr Ricky Chiu Yin-To, CEO, Co-founder, and lead inventor of Part Scientific’s underlying diagnostic know-how. Amongst his most profitable merchandise is OratectXP, the primary FDA accredited drug-of-abuse diagnostic that utilised oral fluid.
– Dr Yiyou Chen, Co-founder, Government Director and Chief Scientist Officer of New Horizon Well being. Chinese language most cancers screening pioneer New Horizon Well being Restricted, has gone IPO in Hong Kong in a mission to go world.
– Prof Roberto Bruzzone, a famend cell biologist, recognised for his work on direct cell-cell communication by means of connexins and their related human ailments. C2i is a vaccine and therapeutics partnership between world infectious ailments chief the Institut Pasteur and the College of Hong Kong.
– Prof Siew Chien Ng, a microbiology knowledgeable, Co-founder of GenieBiome, Professor of CUHK College of Medication, Director of Microbiota I-Heart (MagIC). GenieBiome Restricted (G-NiiB) is a pioneer in intestine well being and has launched the world’s first anti-viral intestine microbiome system.
Driving on the upward trajectory of report €13.49 billion funding in 2022, French startups are looking for additional progress alternatives, whereas the French authorities additionally launched the Healthcare Innovation 2030 plan in 2021 with a funds of €7.5 billion with a objective to steer biotech innovation in Europe.
“The subsequent potential step for French biotech is to scale up and go world. Asia provides various alternatives with Hong Kong the best launchpad for French biotech as an engine of funding, partnerships and expertise to translate and scale medical improvements to world success. French biotech area data and innovation may even be a significant enhance to Hong Kong’s ambition to grow to be a global innovation hub,” mentioned Mr Albert Wong, CEO of HKSTP.
Ecosystem completeness
Hong Kong is Asia’s main and the world’s second largest biotech funding hub with Hong Inventory Trade’s biotech-friendly Chapter 18A itemizing coverage, whereas additionally ranked 12th within the World Index of Healthcare Innovation, above the likes of the UK and Canada. The federal government has additionally funded the InnoHK initiative with 14 analysis clusters devoted to biomedical and well being tech, situated at Hong Kong Science Park.
HKSTP has constructed a thriving absolutely built-in biotech ecosystem that may help ventures by means of each step of the startup to scale-up journey. At the moment HKSTP options round 250 biotech ventures supercharged by incubation programmes such because the devoted Incu-Bio programme, plus engaging subsidies and supportive authorities insurance policies. World class expertise is considerable with Hong Kong’s 5 top-100 universities as ranked by the Instances, plus China’s projected annual output of 77,000 STEM PhDs per 12 months by 2025, in comparison with 40,000 within the US, as estimated by the Heart for Safety and Rising Expertise.
HKSTP has solid highly effective connections with world pharmaceutical leaders similar to Roche, Merck, Boehringer Ingelheim and Shanghai Pharmaceutical, in addition to authorities, private and non-private hospitals and healthcare establishments. These partnerships help all events within the ecosystem to increase into the Larger Bay Space (GBA), China, Asia Pacific and world markets.
Hong Kong already includes a sturdy French contingent and neighborhood with a complete of 800 French companies, together with 373 subsidiaries and 92 regional headquarters based mostly in Hong Kong, based on the French Embassy. events can be part of the HKTSP biotech pavilion and the hear from biotech innovation leaders in addition to different innovation ecosystem consultants on the “Suppose Enterprise Suppose Hong Kong” symposium.
Register now: https://thinkbusinessthinkhk-2023.website.digitevent.com/en/
Study extra: https://thinkbusinessthinkhk.com/2023-paris/symposium/en/event-details/programme.html
Hashtag: #HongKongScienceandTechnologParks
The issuer is solely liable for the content material of this announcement.
[ad_2]
Source link
